Lixte Biotechnology, a clinical-stage pharmaceutical company, closed down 16 percent Wednesday at $4.06 per share, according to Yahoo Finance, after announcing plans to allocate up to 25 percent of its reserves to bitcoin reserves. The sell-off from LIXT comes as investors appear to be switching from bitcoin to Ethereum reserve companies, which until recently were highly sought after, but with a wave of new companies...
After the market closed on Wednesday, U.S. cryptocurrency concept stocks collectively fell after trading, with MicroStrategy (MSTR. O) falling more than 11%, Coinbase (COIN. O) falling more than 6%, Riot Blockchain (RIOT. O) falling nearly 4%, and Robinhood (HOOD. O) falling more than 12%.